LymphaTouch Overview
- Year Founded
-
2005
- Status
-
Private
- Employees
-
7
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$3.01M
- Investors
-
10
LymphaTouch General Information
Description
Developer of therapeutic devices designed to improve patient recovery. The company's devices focus on several treatment areas, including lymphedema, preoperative and postoperative swelling, scarring, fascial tightness, muscle maintenance, active recovery, pain management, and improving joint functionality, enabling healthcare providers to support pain management and the rehabilitation process for patients.
Contact Information
Website
www.lymphatouch.comCorporate Office
- Valimotie 13 A
- 00380 Helsinki
- Finland
Corporate Office
- Valimotie 13 A
- 00380 Helsinki
- Finland
LymphaTouch Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC | 19-Jan-2018 | $3.01M | Completed | Generating Revenue | ||
| 3. Later Stage VC | 18-Jun-2015 | Completed | Generating Revenue | |||
| 2. Later Stage VC | 01-Jan-2012 | Completed | Generating Revenue | |||
| 1. Early Stage VC | 01-Jan-2009 | Completed | Startup |
LymphaTouch Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Class B shares |
LymphaTouch Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
LymphaTouch Patents
LymphaTouch Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2020240088-A1 | Device for regulating suction | Inactive | 27-May-2019 | ||
| EP-3679913-A1 | Treatment head for negative pressure treatment device and negative pressure treatment device | Inactive | 09-Jan-2019 | ||
| WO-2020043931-A1 | Method and system for remote monitoring of an electronic treatment device | Inactive | 28-Aug-2018 | ||
| US-D871591-S1 | Physiotherapy apparatus | Active | 19-Jan-2018 | ||
| US-10973731-B2 | Pulsation massage apparatus | Active | 01-Dec-2010 | A61H7/008 |
LymphaTouch Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
LymphaTouch Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| ACME Investments | Venture Capital | Minority | ||
| Kaikarhenni | Venture Capital | Minority | ||
| Angel (individual) | Minority | |||
| Gerako | Corporation | Minority | ||
| Innovestor | Venture Capital | Minority |
LymphaTouch FAQs
-
When was LymphaTouch founded?
LymphaTouch was founded in 2005.
-
Where is LymphaTouch headquartered?
LymphaTouch is headquartered in Helsinki, Finland.
-
What is the size of LymphaTouch?
LymphaTouch has 7 total employees.
-
What industry is LymphaTouch in?
LymphaTouch’s primary industry is Other Devices and Supplies.
-
Is LymphaTouch a private or public company?
LymphaTouch is a Private company.
-
What is LymphaTouch’s current revenue?
The current revenue for LymphaTouch is .
-
How much funding has LymphaTouch raised over time?
LymphaTouch has raised $4.71M.
-
Who are LymphaTouch’s investors?
ACME Investments, Kaikarhenni, , Gerako, and Innovestor are 5 of 10 investors who have invested in LymphaTouch.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
